Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Other financing activities (2011 - 2022)

Lite Strategy (LITS) posted Other financing activities of $360000.0 for Q1 2022, up 437.31% on a QoQ basis from $67000.0 in Q2 2021, and up 185.71% year-over-year from $126000.0 in Q1 2021.

Analysis

Lite Strategy (LITS) Other financing activities (2011 - 2022) Analysis & Trends

Lite Strategy has reported Other financing activities for 7 years, with the latest figure at $360000.0 in Q1 2022.

  • On a quarterly basis, Other financing activities rose 185.71% year-over-year to $360000.0 in Q1 2022; TTM through Jun 2023 was $360000.0, a 34.9% decrease from a year earlier, with the FY2024 full-year figure at $208000.0, changed N/A from the prior year.
  • Other financing activities was $360000.0 for Q1 2022 at Lite Strategy, up from $67000.0 in the prior quarter.
  • The five-year high for Other financing activities was $70.0 million in Q2 2018, with the low at $15000.0 in Q4 2020.
  • Average Other financing activities over 5 years is $9.6 million, with a median of $243000.0 recorded in 2021.
  • The sharpest annual moves came in 2018 and 2020: Other financing activities soared 5490.0% in 2018, then plunged 97.65% in 2020.
  • Over 5 years, Other financing activities stood at $1.1 million in 2018, then surged by 371.74% to $5.3 million in 2019, then slumped by 99.72% to $15000.0 in 2020, then jumped by 346.67% to $67000.0 in 2021, then soared by 437.31% to $360000.0 in 2022.
  • The last three Other financing activities figures came in at $360000.0 (Q1 2022), $67000.0 (Q2 2021), and $126000.0 (Q1 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Lite Strategy 38.03 Mn 30.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 360,000.00
Jun 30, 2021 67,000.00
Mar 31, 2021 126,000.00
Dec 31, 2020 15,000.00
Sep 30, 2020 124,000.00
Sep 30, 2019 5.27 Mn
Sep 30, 2018 1.12 Mn
Jun 30, 2018 69.96 Mn
Dec 31, 2017 169,000.00
Sep 30, 2017 20,000.00
Dec 31, 2011 365,000.00
Sep 30, 2011 397,000.00